Top Markets
Coin of the day
Medicure Inc. Medicure Inc.

Medicure Inc.

MPH
Classifica tra le azioni #32231
Medicure Inc. is a biopharmaceutical firm focused on developing, researching,... Medicure Inc. is a biopharmaceutical firm focused on developing, researching, and commercializing therapeutic solutions for cardiovascular conditions across Canada and the United States. Its product portfolio includes AGGRASTAT, an injectable glycoprotein GP IIb/IIIa receptor antagonist prescribed for acute coronary syndromes, such as unstable angina and non-Q-wave myocardial infarction. The company also provides ZYPITAMAG, a medication used to manage primary hyperlipidemia and mixed dyslipidemia. Additionally, Medicure offers the ReDS system, a non-invasive medical device designed to measure lung fluid levels, aiding in the management of congestive heart failure. Another key offering is Sodium Nitroprusside injection, utilized for rapidly lowering blood pressure during hypertensive crises in both adult and pediatric patients, inducing controlled hypotension for surgical bleeding reduction, and treating acute congestive heart failure. These products are made available through both retail pharmacy networks and online platforms. Established in 1997, Medicure Inc. is headquartered in Winnipeg, Canada.
Prezzo delle azioni
$1.02
Ultima sincronizzazione: 2026-08-17
Capitalizzazione di mercato
$10.65M
Variazione (1 giorno)
2.21%
Variazione (1 anno)
34.07%
Paese
CA
Scambia Medicure Inc. (MPH)

Categoria

Storico del rendimento da dividendi per Medicure Inc. (MPH)
Il rendimento da dividendi (TTM) di Medicure Inc. (simbolo azionario: MPH) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Medicure Inc. (MPH) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti